Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pedro Coelho Barata"'
Autor:
Diogo Alpuim Costa, Susana Baptista de Almeida, Pedro Coelho Barata, António Quintela, Pedro Cabral, Ana Afonso, João Maia Silva
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 1041-1049 (2017)
In phase II/III trials, cutaneous side effects of pazopanib were reported in less than 20% of patients, with only 1–3% being grade 3/4. We present a case of a 66-year-old man with a previous history of left nephrectomy for a stage II clear cell ren
Externí odkaz:
https://doaj.org/article/7e8e5b7948a04fb8b32a4c2ce8a76ed1
Publikováno v:
Acta Médica Portuguesa, Vol 31, Iss 7-8, Pp 373-375 (2018)
N/A.
Externí odkaz:
https://doaj.org/article/b56613cb4ca4453682c675a036441ac3
Autor:
Diogo Alpuim Costa, Susana Baptista de Almeida, Pedro Coelho Barata, António Quintela, Pedro Cabral, Ana Afonso, João Maia Silva
Publikováno v:
Gazeta Médica, Vol 5, Iss 1 (2018)
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).
Externí odkaz:
https://doaj.org/article/1bde443187f84435b4964b88251bf5cd
Autor:
Pedro Coelho Barata, Joana Morgado, Ana Paula Sousa, Sónia Duarte de Oliveira, Maria Paula Custódio, Lígia Bruno da Costa, José Esteves Pena
Publikováno v:
Case Reports in Oncology, Vol 5, Iss 3, Pp 616-621 (2012)
Background: Paraneoplastic neurologic syndromes (PNS) pose quite an uncommon neurological complication, affecting less than 1% of patients with breast cancer. Nearly one third of these patients lack detectable onconeural antibodies (ONAs), and improv
Externí odkaz:
https://doaj.org/article/ddfcf91de00f44c788f3be339af283b0